Definitive Research And Ddevelopement To Revenue from 2010 to 2024

DH Stock  USD 4.46  0.03  0.67%   
Definitive Healthcare's Research And Ddevelopement To Revenue is increasing with slightly volatile movements from year to year. Research And Ddevelopement To Revenue is predicted to flatten to 0.1. Research And Ddevelopement To Revenue is the ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services. View All Fundamentals
 
Research And Ddevelopement To Revenue  
First Reported
2010-12-31
Previous Quarter
0.16880854
Current Value
0.096
Quarterly Volatility
0.02647951
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Definitive Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Definitive Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 57.6 M, Interest Expense of 16.7 M or Selling General Administrative of 35.5 M, as well as many indicators such as Price To Sales Ratio of 4.24, Dividend Yield of 0.0115 or PTB Ratio of 1.24. Definitive financial statements analysis is a perfect complement when working with Definitive Healthcare Valuation or Volatility modules.
  
Check out the analysis of Definitive Healthcare Correlation against competitors.

Latest Definitive Healthcare's Research And Ddevelopement To Revenue Growth Pattern

Below is the plot of the Research And Ddevelopement To Revenue of Definitive Healthcare Corp over the last few years. It is the ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services. Definitive Healthcare's Research And Ddevelopement To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Definitive Healthcare's overall financial position and show how it may be relating to other accounts over time.
Research And Ddevelopement To Revenue10 Years Trend
Slightly volatile
   Research And Ddevelopement To Revenue   
       Timeline  

Definitive Research And Ddevelopement To Revenue Regression Statistics

Arithmetic Mean0.1
Geometric Mean0.1
Coefficient Of Variation26.52
Mean Deviation0.02
Median0.09
Standard Deviation0.03
Sample Variance0.0007
Range0.0817
R-Value0.61
Mean Square Error0.0005
R-Squared0.38
Significance0.01
Slope0
Total Sum of Squares0.01

Definitive Research And Ddevelopement To Revenue History

2024 0.096
2023 0.17
2022 0.16
2021 0.11
2020 0.0935

About Definitive Healthcare Financial Statements

Investors use fundamental indicators, such as Definitive Healthcare's Research And Ddevelopement To Revenue, to determine how well the company is positioned to perform in the future. Although Definitive Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Research And Ddevelopement To Revenue 0.17  0.10 

Currently Active Assets on Macroaxis

Check out the analysis of Definitive Healthcare Correlation against competitors.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.09)
Revenue Per Share
2.187
Quarterly Revenue Growth
(0.04)
Return On Assets
(0.01)
Return On Equity
(0.55)
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Definitive Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.